Accelerated Approval for Beleodaq

Shares of Spectrum Pharmaceuticals (NASDAQ: SPPI) gained 5.7 percent following the U.S. Food and Drug Administration's approval of the New Drug Application (NDA) for Beleodaq. Accelerated Approval for Beleodaq In an 8-K filing on Wednesday, Spectrum reported that it gained accelerated...